4.7 Article

Mathematical models for devising the optimal SARS-CoV-2 strategy for eradication in China, South Korea, and Italy

期刊

JOURNAL OF TRANSLATIONAL MEDICINE
卷 18, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s12967-020-02513-7

关键词

COVID-19; SARS-CoV-2; Mathematical models; Hospital isolation

资金

  1. National Special Research Program of China for Important Infectious Diseases [2018ZX10302103-003]
  2. [81672383]

向作者/读者索取更多资源

Background Coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spreads rapidly and has attracted worldwide attention. Methods To improve the forecast accuracy and investigate the spread of SARS-CoV-2, we constructed four mathematical models to numerically estimate the spread of SARS-CoV-2 and the efficacy of eradication strategies. Results Using the Susceptible-Exposed-Infected-Removed (SEIR) model, and including measures such as city closures and extended leave policies implemented by the Chinese government that effectively reduced the beta value, we estimated that the beta value and basic transmission number,R-0, of SARS-CoV-2 was 0.476/6.66 in Wuhan, 0.359/5.03 in Korea, and 0.400/5.60 in Italy. Considering medicine and vaccines, an advanced model demonstrated that the emergence of vaccines would greatly slow the spread of the virus. Our model predicted that 100,000 people would become infected assuming that the isolation rate alpha in Wuhan was 0.30. If quarantine measures were taken from March 10, 2020, and the quarantine rate of alpha was also 0.3, then the final number of infected people was predicted to be 11,426 in South Korea and 147,142 in Italy. Conclusions Our mathematical models indicate that SARS-CoV-2 eradication depends on systematic planning, effective hospital isolation, and SARS-CoV-2 vaccination, and some measures including city closures and leave policies should be implemented to ensure SARS-CoV-2 eradication.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据